# Live From WCLC 2025: Monday Highlights

An episode of [Lung Cancer Considered](https://invisiblenetwork.ai/podcast/1655997630), 8 Sep 2025, 42 min.

Audio: https://feeds.soundcloud.com/stream/2167176324-lungcancerconsidered-live-from-wclc-2025-monday-highlights.mp3

In this special WCLC 2025 episode of Lung Cancer Considered, hosts Dr. Narjust Florez and Dr. Stephen Liu discuss daily highlights from the conference. Dr. Tina Cascone discusses results from the NADIM ADJUVANT Phase III trial. Dr. Jacie Jiaqi Law shares survival outcomes of VATS compared to open lobectomy, and Dr. Corinne Faivre-Finn and Dr. Shankar Siva summarize results from the EA5181 trial of concurrent and consolidation durvalumab after chemoradiation for unresectable NSCLC and hypofractionation vs conventional fractionation for LS SCLC.

Shows are listed from Apple Podcasts' charts and directory, and Podcast Index where it is used. Every show and episode belongs to its publisher and plays from the publisher's own feed; this site hosts none of them.